Abstract
Lipophilic inhibitors of angiotensin-converting enzyme increased 6-month survival and/or lifetime of rats with experimental chronic heart failure. These drugs had no effect on the mortality rate of animals with acute decompensation of the disease. β-Adrenoceptor blockers without intrinsic sympathomimetic activity not only prolonged 6-month survival and lifetime, but also decreased the mortality rate of rats with decompensation of chronic heart failure.
Similar content being viewed by others
References
G. P. Arutyunov, Zh. Serdech. Nedostatoch., 5, No. 2, 64–65 (2004).
G. P. Arutyunov and A. K. Rylova, Ibid., 2, No. 2, 92–94 (2001).
S. Glants, Medical and Biological Statistics [in Russian], Moscow (1999).
T. A. Gus’kova, Khim.-Farm. Zh., No. 7, 10–15 (1990).
A. G. Obrezan and I. V. Vologdina, Chronic Heart Failure [in Russian], St. Petersburg (2002).
D. V. Preobrazhenskii, B. A. Sidorenko, and T. A. Batyraliev, ACE Inhibitors and AT 1 Receptor Antagonists in Clinical Practice [in Russian], Moscow (2002).
V. N. Fedorov, A. L. Khokhlov, and O. V. Smirnova, Ros. Kardiol. Zh., 33, No. 1, 56–58 (2002).
M. Bristow, Circulation, No. 101, 558–569 (2000).
P. A. Poole-Wilson, R. Swedberg, J. G. F. Cleland, et al., Lancet, No. 362, 7–14 (2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 141, No. 1, pp. 45–48, January, 2006
Rights and permissions
About this article
Cite this article
Fedorov, V.N., Sal’nikov, E.V., Sidorov, A.V. et al. Survival of rats with experimental chronic heart failure depending on pharmacodynamic and pharmacokinetic parameters of angiotensin-converting enzyme inhibitors and β-adrenoceptor blockers. Bull Exp Biol Med 141, 40–43 (2006). https://doi.org/10.1007/s10517-006-0088-1
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10517-006-0088-1